Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1H)-One Scaffold

A growing body of evidence underlines the crucial role of GPR55 in physiological and pathological conditions. In fact, GPR55 has recently emerged as a therapeutic target for several diseases, including cancer and neurodegenerative and metabolic disorders. Several lines of evidence highlight GPR55′s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceni, Costanza, Benko, Michael J., Mohamed, Kawthar A., Poli, Giulio, Di Stefano, Miriana, Tuccinardi, Tiziano, Digiacomo, Maria, Valoti, Massimo, Laprairie, Robert B., Macchia, Marco, Bertini, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320067/
https://www.ncbi.nlm.nih.gov/pubmed/35890067
http://dx.doi.org/10.3390/ph15070768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320067/
https://www.ncbi.nlm.nih.gov/pubmed/35890067
http://dx.doi.org/10.3390/ph15070768

Ejemplares similares